Akebia Therapeutics, Inc. (AKBA) News

Akebia Therapeutics, Inc. (AKBA): $3.97

0.28 (+7.59%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add AKBA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#72 of 302

in industry

Filter AKBA News Items

AKBA News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!